Medical Robotics Market by Product Type (Surgical Robotic Systems, Rehabilitation Robotic Systems, Hospital & Pharmacy Automation Robots, Non-Invasive Radiosurgery Robots), by Application (Orthopedic Surgery, Neurology, Urology, Gynecology, Cardiology, Laparoscopy & General Surgery), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, Rehabilitation Centers, Academic & Research Institutes), by Component (Instruments & Accessories, Systems, Services), and by Region — Global Industry Perspective, Comprehensive Analysis, and Forecast 2026–2035
St. Catharines, Ontario, November 2026 — Vectomat Insights has published a new report titled ‘Medical Robotics Market by Product Type, Application, End User, Component, and Region — Global Industry Perspective, Comprehensive Analysis, and Forecast 2026–2035.’ The Global Medical Robotics market was valued at USD 10,241.8 Mn in 2025 and is projected to reach USD 50,680.1 Mn by 2035, growing at a CAGR of 17.34% during the forecast period 2026–2035, according to Vectomat Insights.
Surgical robotic systems take the largest slice at 43.3% of 2025 revenue, but it's rehabilitation robots — compounding at 23.05% a year — and a wave of new soft-tissue platforms from Medtronic, CMR Surgical and Johnson & Johnson MedTech that are reshaping the race, while North America holds 40.0% of global spend.
The Global Medical Robotics market reached USD 10,241.8 Mn in 2025 and is projected to hit USD 50,680.1 Mn by 2035, a 17.34% CAGR over 2026–2035, according to Vectomat Insights. North America leads with a 40.0% share, surgical robotic systems hold 43.3% of revenue, and Asia Pacific is the fastest-growing region as Japanese and Chinese platforms scale.
Key Insights Snapshot
| Metric | Value |
|---|---|
| Report Title | Global Medical Robotics Market Size, Share, Growth & Forecast By Product Type, Application, End User, and Component, 2026–2035 |
| Base Year Market Size | USD 10,241.8 Mn (2025) |
| Forecast Market Size | USD 50,680.1 Mn (2035) |
| CAGR | 17.34% |
| Forecast Period | 2026–2035 |
| Dominant Region | North America (40.0%) |
| Fastest-Growing Region | Asia Pacific |
| Dominant Segment | Surgical Robotic Systems (43.3%) |
| Dominant Application | Orthopedic Surgery |
| Report Format | |
| Publisher | Vectomat Insights |
What Medical Device Leaders Need to Know About the Medical Robotics Market
Hospital CEOs and CFOs: Robot pricing power is shifting toward buyers for the first time: Hugo, Versius Plus and Ottava all won U.S. authorization between December 2025 and July 2026. Capital plans signed this year should build in competitive tendering and utilisation guarantees rather than single-source renewals.
Chief Medical Officers and Surgical Chiefs: Neurology robotics is compounding at 24.62% a year, the fastest application in the market. Programs that credential surgeons on only one platform now carry vendor-dependency risk as multi-platform fleets become normal.
MedTech Product and R&D Heads: Services grow at 25.34% a year against 9.73% for system hardware. Roadmaps that monetise uptime, training and software after the sale will capture more of the USD 50,680.1 Mn forecast than those built around capital sales.
Regulatory Affairs Directors: The FDA's September 2026 draft guidance on robotically-assisted surgical device submissions resets evidence expectations. Teams preparing 510(k) or De Novo files in 2027 should align bench, cadaver and clinical data plans with it now.
Healthcare Investors: Consolidation is accelerating: Zimmer Biomet closed Monogram in October 2025, and Stryker's USD 400 Mn CMR alliance carries an acquisition option. Sub-scale soft-tissue and exoskeleton vendors are the likeliest next targets.
What Is the Medical Robotics Market?
Medical Robotics Market refers to robotic systems that assist clinicians in surgery, rehabilitation, radiosurgery and hospital or pharmacy logistics. Why now? Because the single-vendor era in soft-tissue surgery ended in eight months: Medtronic's Hugo and CMR Surgical's Versius Plus both cleared the FDA in December 2025, and Johnson & Johnson MedTech's Ottava won U.S. market authorization in July 2026. More choice means sharper pricing and new buyers, from ambulatory surgical centers to mid-size hospitals. Vectomat Insights sizes the category at USD 10,241.8 Mn in 2025, rising to USD 50,680.1 Mn by 2035.
How Is the Medical Robotics Market Segmented?
Surgical robotic systems take 43.3% of 2025 revenue, and that lead won't slip soon — every da Vinci, Mako or Hugo case pulls through proprietary instruments. The faster story is elsewhere. Rehabilitation robots are compounding at 23.05% a year, and neurology is the fastest-growing application at 24.62%. On the buyer side, ambulatory surgical centers are scaling at 23.28% as compact systems like Distalmotion's Dexter go outpatient. Instruments and accessories already earn 54.0% of revenue; services grow fastest at 25.34%, as fleets age into maintenance and software contracts.
This report segments the Medical Robotics market as follows:
- By Product Type: Surgical Robotic Systems, Rehabilitation Robotic Systems, Hospital & Pharmacy Automation Robots, Non-Invasive Radiosurgery Robots
- By Application: Orthopedic Surgery, Neurology, Urology, Gynecology, Cardiology, Laparoscopy & General Surgery
- By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Rehabilitation Centers, Academic & Research Institutes
- By Component: Instruments & Accessories, Systems, Services
- By Region: North America, Europe, Asia Pacific, Latin America, The Middle East, Africa
Which Region Leads the Medical Robotics Market?
North America commands 40.0% of the 2025 market, worth USD 4,096.8 Mn, and the United States alone accounts for USD 3,047.7 Mn. It's also where competition just arrived: Medtronic's Hugo and CMR Surgical's Versius Plus were both cleared there in December 2025. Asia Pacific is the fastest-growing region — South Korea's market is set to expand at 19.4% a year and Japan's at 17.8%, while China's 2025 pricing items for robotic surgery open public hospital demand. Europe holds 25.7%, led by Germany at USD 755.7 Mn. Latin America (6.6%), the Middle East (4.8%) and Africa (2.0%) are smaller but adding programs fast.
What Is Driving the Medical Robotics Market?
Procedure Adoption Momentum — Robotic procedure volumes are still compounding: Intuitive Surgical guided 13–15% worldwide da Vinci procedure growth for 2026 in January 2026.
Multi-Vendor Soft-Tissue Platforms — Three rival soft-tissue robots reached the U.S. market in eight months — Medtronic's Hugo and CMR Surgical's Versius Plus cleared in December 2025, and J&J MedTech's Ottava won authorization in July 2026.
Orthopedic Robotics Expansion and M&A — Orthopedic robotics is consolidating: Zimmer Biomet closed Monogram in October 2025, and Stryker committed USD 400 Mn to CMR Surgical in October 2026.
Demand for da Vinci 5 and its utilisation have run ahead of our expectations, and we are working to widen robotic adoption into general and acute-care surgery. (paraphrased)
(Source: Intuitive Q4 2025 earnings call, as reported by MassDevice, 2026-01)
What Is Restraining the Medical Robotics Market?
High Capital and Ownership Cost — A single surgical robot can cost a hospital more than USD 2.3 Mn before instruments and service — a hard sell for mid-size hospitals.
Payer and Reimbursement Volatility — Coverage shocks hit procedure volumes fast: Intuitive tied slower U.S. procedure growth in Q2 2026 to expiring ACA subsidies.
Despite these challenges, the market is set to grow from USD 10,241.8 Mn in 2025 to USD 50,680.1 Mn by 2035.
What Industry Leaders Are Saying About the Medical Robotics Market
Having more than one robotic platform available gives health systems real choice and brings competition into robotic surgery. (paraphrased)
(Source: HPN Online, first U.S. Hugo prostatectomy coverage, 2026-02)
The alliance with CMR Surgical extends Stryker's robotics leadership from orthopedics into soft-tissue surgery. (paraphrased)
(Source: Stryker press release (SEC Form 8-K exhibit), 2026-10)
U.S. procedure growth slowed in the second quarter as enhanced ACA subsidies expired and GLP-1 drugs weighed on bariatric volumes. (paraphrased)
(Source: Intuitive Q2 2026 earnings call, as reported by MedTech Dive, 2026-07)
Training, credentialing and governance have to keep pace as robotic-assisted surgery rolls out across NHS hospitals. (paraphrased)
(Source: RCS England updated robotic-assisted surgery guidance, 2025-12)
Report Segmentation & Scope
| Vectomat Insights | Market & Reports — Report Segmentation & Scope | |
|---|---|
| Scope Included in the Study | |
| By Product Type |
|
| By Application |
|
| By End User |
|
| By Component |
|
| Regional Analysis | |
| North America | The U.S., Canada, Mexico |
| Europe | Germany, France, U.K., Italy, Spain, Russia, BENELUX, Sweden, Denmark, Poland, Austria, Rest of Europe |
| Asia Pacific | China, Japan, India, South Korea, Australia, Thailand, Indonesia, Vietnam, Malaysia, Philippines, Taiwan, Rest of Asia Pacific |
| Latin America | Brazil, Argentina, Colombia, Chile, Peru, Rest of Latin America |
| The Middle East | GCC (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman), Israel, Turkey, Iran, Rest of Middle East |
| Africa | South Africa, Egypt, Nigeria, Algeria, Morocco, Rest of Africa |
| Note: The scope can be further tailored as per your specific requirement. Contact sales@vectomatinsights.com | |
Who Are the Leading Companies in the Medical Robotics Market?
Key players operating in the Global Medical Robotics market include Intuitive Surgical (U.S.), Medtronic (Ireland), Stryker (U.S.), Johnson & Johnson MedTech (U.S.), Zimmer Biomet (U.S.), CMR Surgical (U.K.), Medicaroid (Japan), MicroPort MedBot (China), SS Innovations (India), Distalmotion (Switzerland), Accuray (U.S.), Wandercraft (France), Lifeward (Israel), Omnicell (U.S.), Swisslog Healthcare (Switzerland), among others. Intuitive Surgical still sets the pace in soft tissue, but the field just got crowded: three rival soft-tissue platforms won U.S. authorization between December 2025 and July 2026. Orthopedics is consolidating fast, and rehabilitation is next. Expect sharper price competition once those new systems reach U.S. hospitals in volume.
What Recent Developments Are Shaping the Medical Robotics Market?
October 2025 — Zimmer Biomet: Completed the acquisition of Monogram Technologies, a developer of semi- and fully autonomous orthopedic robotics.
December 2025 — Medtronic: Received FDA clearance for the Hugo robotic-assisted surgery system in urologic procedures.
December 2025 — CMR Surgical: Received FDA 510(k) clearance for the Versius Plus surgical robotic system.
July 2026 — Johnson & Johnson MedTech: Received FDA De Novo market authorization for the Ottava robotic surgical system.
July 2026 — Medicaroid: Received EU CE marking under MDR for the hinotori surgical robot system.
October 2026 — Stryker / CMR Surgical: Announced a strategic alliance in which Stryker invests USD 400 Mn in CMR Surgical with an option to acquire it.
Frequently Asked Questions
What is the Medical Robotics market size and forecast?
The Global Medical Robotics market was valued at USD 10,241.8 Mn in 2025 and is forecast to reach USD 50,680.1 Mn by 2035, growing at a 17.34% CAGR during 2026–2035. North America leads with a 40.0% revenue share, and surgical robotic systems remain the largest product type at 43.3% of 2025 revenue, while rehabilitation robots grow fastest at a 23.05% CAGR, according to Vectomat Insights.
Which region dominates the Medical Robotics market?
North America dominates with a 40.0% share of 2025 revenue (USD 4,096.8 Mn), led by the United States at USD 3,047.7 Mn. Europe follows at 25.7%, led by Germany at USD 755.7 Mn. Asia Pacific is the fastest-growing region, with South Korea forecast at a 19.4% CAGR and Japan at 17.8% as domestic platforms such as hinotori and Toumai scale, according to Vectomat Insights.
What are the key growth drivers of the Medical Robotics market?
Growth comes from rising robotic procedure volumes, with Intuitive Surgical guiding 13–15% da Vinci procedure growth for 2026; a wave of new soft-tissue platforms, including Medtronic's Hugo and CMR Surgical's Versius Plus, both FDA-cleared in December 2025; and orthopedic robotics expansion, highlighted by Stryker's USD 400 Mn alliance with CMR Surgical in October 2026. Telesurgery and AI-assisted features add a further growth layer through 2035, according to Vectomat Insights.
Who are the leading companies in the Medical Robotics market?
Leading companies include Intuitive Surgical, Medtronic, Stryker, Johnson & Johnson MedTech, Zimmer Biomet, CMR Surgical, Medicaroid, MicroPort MedBot, SS Innovations, Distalmotion, Accuray, Wandercraft, Lifeward, Omnicell and Swisslog Healthcare. Competition is sharpest in soft-tissue surgery, where three new platforms won U.S. authorization between December 2025 and July 2026. Asian challengers compete mainly on price and telesurgery capability, according to Vectomat Insights.
How is the Medical Robotics market segmented?
The market is segmented by Product Type (Surgical Robotic Systems dominant at 43.3%), Application (Orthopedic Surgery dominant at 29.7%; Neurology fastest-growing), End User (Hospitals & Clinics dominant at 46.2%; Ambulatory Surgical Centers fastest-growing), Component (Instruments & Accessories dominant at 54.0%), and by Region across all six VMI geographies (the Middle East and Africa are separate regions), with country-level data for 35+ markets, according to Vectomat Insights.
How can I access the full VMI Medical Robotics market report?
The full VMI Medical Robotics market report is available as a free sample, a full purchase or a custom inquiry through the Vectomat Insights website. It covers 300+ pages, four segmentation dimensions, 35+ countries and 15 company profiles. For custom scope, such as extra countries or a longer forecast, contact sales@vectomatinsights.com. Country-level tables and Excel data are available on request, according to Vectomat Insights.
Access the Complete Medical Robotics Market Report
300+ pages | Global coverage | PDF | 2026
Contact: sales@vectomatinsights.com
About Vectomat Insights
Vectomat Insights is a leading market research company. We create authoritative, data-forward reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organisations but also with the newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is updated constantly in order to fulfil our clients' requirements for prompt and direct online access. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database.
Contact: Vectomat Insights | Email: sales@vectomatinsights.com | Website: www.vectomatinsights.com · +1 416-876-0312